Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model

Stem Cells Translational Medicine

Volumn 5, Issue 12, 2016, Pages 1620-1630

  Furuta, Taisuke ^a   Miyaki, Shigeru ^a,b   Ishitobi, Hiroyuki ^b   Ogura, Toshihiko ^c   Kato, Yoshio ^c   Kamei, Naosuke ^a,b   Miyado, Kenji ^d   Higashi, Yukihito ^b   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Cytokine; Endochondral ossification; Exosomes; Fracture healing; Mesenchymal stem cells; microRNA

Indexed keywords

CD81 ANTIGEN; CD9 ANTIGEN; CYTOKINE; FLOTILLIN 1; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; CONDITIONED MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE RADIOGRAPHY; CALLUS; CARTILAGE CELL; CONDITIONED MEDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXOSOME; FEMUR SHAFT FRACTURE; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FRACTURE HEALING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MRNA EXPRESSION ASSAY; NONHUMAN; PROTEIN EXPRESSION; TISSUE REPAIR; ANIMAL; C57BL MOUSE; CYTOLOGY; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; TIBIA; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD9; BODY WEIGHT; BONE DENSITY; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; EXOSOMES; FRACTURE HEALING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICRORNAS; TIBIA;

EID: 84995893195     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0285     Document Type: Article

References (59)

1. Rhinelander FW, Baragry R. Microangiography in bone healing. I. Undisplaced closed fractures. J Bone Joint Surg 1962;44-A: 1273–1298.
2. Enneking WF, Eady JL, Burchardt H. Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. J Bone Joint Surg Am 1980;62:1039–1058.
3. Kodama A, Kamei N, Kamei G et al. In vivo bioluminescence imaging of transplanted bone marrow mesenchymal stromal cells using a magnetic delivery system in a rat fracture model. J Bone Joint Surg Br 2012;94:998–1006.
4. Granero-Moltó F, Myers TJ, Weis JA et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: Analyses of MSCIGF autocrine and paracrine regenerative effects. STEM CELLS 2011;29:1537–1548.
5. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9–20.
6. Watson L, Elliman SJ, Coleman CM. From isolation to implantation: A concise review of mesenchymal stem cell therapy in bone fracture repair. Stem Cell Res Ther 2014;5:51.
7. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076–1084.
8. Granero-Moltó F, Weis JA, Miga MI et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. STEM CELLS 2009;27:1887–1898.
9. Gerstenfeld LC, Cullinane DM, Barnes GL et al. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation.J Cell Biochem 2003; 88:873–884.
10. Liang X, Ding Y, Zhang Y et al. Paracrine mechanisms of mesenchymal stem cell-based therapy: Current status and perspectives. Cell Transplant 2014;23:1045–1059.
11. Toupadakis CA, Wong A, Genetos DC et al. Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. J Orthopaedic Res 2012;30:11 1853–1859.
12. Ishikawa M, Ito H, Kitaori T et al. MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing. PLoS One 2014;9:e104954.
13. Kitaori T, Ito H, Schwarz EM et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009;60:813–823.
14. Ando Y, Matsubara K, Ishikawa J et al. Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms. Bone 2014;61:82–90.
15. Mu J, Zhuang X, Wang Q et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr Food Res 2014;58:1561–1573.
16. Ludwig AK, Giebel B. Exosomes: Small vesicles participating in intercellular communication. Int J Biochem Cell Biol 2012;44: 11–15.
17. Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor. Cell 1983;33:967–978.
18. Johnstone RM. Exosomes biological significance: A concise review. Blood Cells Mol Dis 2006;36:315–321.
19. Zakharova L, Svetlova M, Fomina AF. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 2007;212: 174–181.
20. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009;9:581–593.
21. Mathivanan S, Ji H, Simpson RJ. Exosomes: Extracellular organelles important in intercellular communication. J Proteomics 2010; 73:1907–1920.
22. Iwasaki T, Takeda Y, Maruyama K et al. Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro. J Biol Chem 2013;288:2118–2131.
23. Kamisasanuki T, Tokushige S, Terasaki H et al. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: A novel antiangiogenic therapy. Biochem Biophys Res Commun 2011; 413:128–135.
24. Qi JC, Wang J, Mandadi S et al. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood 2006;107:135–142.
25. Record M. Intercellular communication by exosomes in placenta: A possible role in cell fusion? Placenta 2014;35:297–302.
26. Dou C, Li J, Kang F et al. Dual effect of cyanidin on RANKL-induced differentiation and fusion of osteoclasts. J Cell Physiol 2016;231: 558–567.
27. Tachibana I, Hemler ME. Role of trans-membrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 1999;146: 893–904.
28. Miyado K, Yamada G, Yamada S et al. Requirement of CD9 on the egg plasma membrane for fertilization. Science 2000;287: 321–324.
29. Ishii M, Iwai K, Koike M et al. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res 2006;21:6965–976.
30. Yi T, Kim HJ, Cho JY et al. Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity. Biochem Biophys Res Commun 2006;347:178–184.
31. Miyado K, Yoshida K, Yamagata K et al. The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice. Proc Natl Acad Sci USA 2008;105: 12921–12926.
32. Chairoungdua A, Smith DL, Pochard P et al. Exosome release of b-catenin: A novel mechanism that antagonizes Wnt signaling. J Cell Biol 2010;190:1079–1091.
33. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:1053–1067.
34. Herrera MB, Fonsato V, Gatti S et al. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 2010;14(6b): 1605–1618.
35. Lai RC, Arslan F, Lee MM et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res (Amst) 2010;4:214–222.
36. Nakamura Y, Miyaki S, Ishitobi H et al. Mesenchymal-stem-cell-derived exosomes accelerateskeletal muscleregeneration. FEBS Lett 2015;589:1257–1265.
37. Maes C, Coenegrachts L, Stockmans I et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 2006;116:1230–1242.
38. Oetgen ME, Merrell GA, Troiano NW et al. Development of a femoral non-union model in the mouse. Injury 2008;39:1119–1126.
39. Ogura T. Nanoscale analysis of unstained biological specimens in water without radiation damage using high-resolution frequency transmission electric-field system based on FE-SEM. Biochem Biophys Res Commun 2015;459: 521–528.
40. Zhang J, Dong J, Gu H et al. CD9 is critical for cutaneous wound healing through JNK signaling. J Invest Dermatol 2012;132: 226–236.
41. Charrin S, Latil M, Soave S et al. Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81. Nat Commun 2013;4:1674.
42. Kawano N, Miyado K, Yoshii N et al. Absence of CD9 reduces endometrial VEGF secretion and impairs uterine repair after parturition. Sci Rep 2014;4:4701.
43. Takeda Y, Tachibana I, Miyado K et al. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol 2003;161:945–956.
44. Leung KT, Chan KY, Ng PC et al. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells. Blood 2011; 117:1840–1850.
45. Brzoska E, Kowalski K, Markowska-Zagrajek A et al. Sdf-1 (CXCL12) induces CD9 expression in stem cells engaged in muscle regeneration. Stem Cell Res Ther 2015;6: 46.
46. Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Arch Biochem Biophys 2014;561:109–117.
47. Wang CY, Yang HB, Hsu HS et al. Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats. J Tissue Eng Regen Med 2012;6: 559–569.
48. Valadi H, Ekström K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9: 654–659.
49. Zhang Y, Liu D, Chen X et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010;39:133–144.
50. Kosaka N, Iguchi H, Yoshioka Y et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285:17442–17452.
51. Li H, Yang F, Wang Z et al. MicroRNA-21 promotes osteogenic differentiation by targeting small mothers against decapentaplegic 7. Mol Med Rep 2015;12:1561–1567.
52. Meng YB, Li X, Li ZY et al. microRNA-21 promotes osteogenic differentiation of mesenchymal stem cells by the PI3K/beta-catenin pathway. J Orthop Res 2015;33:7957–964.
53. Sun Y, Xu L, Huang S et al. mir-21 overexpressing mesenchymal stem cells accelerate fracture healing in a rat closed femur fracture model. BioMed Res Int 2015;2015:412327.
54. Baglio SR, Rooijers K, Koppers-Lalic D et al. Humanbone marrow-andadipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther 2015;6:127.
55. Kato T, Miyaki S, Ishitobi H et al. Exosomes from IL-1b stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther 2014;16:R163.
56. Miyaki S, Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012;8:543–552.
57. Alvarez-Erviti L, Seow Y, Yin H et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341–345.
58. Ohno S, Takanashi M, Sudo K et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013;21:1185–191.
59. Shimbo K, Miyaki S, Ishitobi H et al. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. Biochem Biophys Res Commun 2014;445:381–387.